IS6582A - Mótunarpeptíð fyrir blóðkökkmyndunarviðtaka - Google Patents

Mótunarpeptíð fyrir blóðkökkmyndunarviðtaka

Info

Publication number
IS6582A
IS6582A IS6582A IS6582A IS6582A IS 6582 A IS6582 A IS 6582A IS 6582 A IS6582 A IS 6582A IS 6582 A IS6582 A IS 6582A IS 6582 A IS6582 A IS 6582A
Authority
IS
Iceland
Prior art keywords
blood cell
cell receptors
formulation peptide
peptide
formulation
Prior art date
Application number
IS6582A
Other languages
English (en)
Inventor
Naranda Tatjana
Olsson Lennart
Original Assignee
Pliva, Farmaceutska Industrija, Dionicko Drustvo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva, Farmaceutska Industrija, Dionicko Drustvo filed Critical Pliva, Farmaceutska Industrija, Dionicko Drustvo
Publication of IS6582A publication Critical patent/IS6582A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IS6582A 2000-04-25 2002-10-14 Mótunarpeptíð fyrir blóðkökkmyndunarviðtaka IS6582A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00108075A EP1149906A1 (en) 2000-04-25 2000-04-25 Thrombopoietin receptor modulating peptide
PCT/EP2001/004553 WO2001080873A2 (en) 2000-04-25 2001-04-23 Thrombopoietin receptor modulating peptide

Publications (1)

Publication Number Publication Date
IS6582A true IS6582A (is) 2002-10-14

Family

ID=8168467

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6582A IS6582A (is) 2000-04-25 2002-10-14 Mótunarpeptíð fyrir blóðkökkmyndunarviðtaka

Country Status (24)

Country Link
US (1) US20030181659A1 (is)
EP (2) EP1149906A1 (is)
JP (1) JP2003530867A (is)
KR (1) KR20030009450A (is)
CN (1) CN1426467A (is)
AR (1) AR030278A1 (is)
AU (2) AU6736601A (is)
BG (1) BG107214A (is)
BR (1) BR0110383A (is)
CA (1) CA2407167A1 (is)
CZ (1) CZ20023517A3 (is)
EA (1) EA006423B1 (is)
EE (1) EE200200610A (is)
GE (1) GEP20063763B (is)
HU (1) HUP0300559A3 (is)
IL (1) IL152204A0 (is)
IS (1) IS6582A (is)
MX (1) MXPA02010458A (is)
NO (1) NO20025114L (is)
PL (1) PL358304A1 (is)
SK (1) SK15262002A3 (is)
WO (1) WO2001080873A2 (is)
YU (1) YU79202A (is)
ZA (1) ZA200208662B (is)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002359362A1 (en) * 2001-11-07 2003-05-19 Millennium Pharmaceuticals, Inc. Methods and compositions for treating hematological disorders using 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692 or 58874
US7923431B2 (en) * 2001-12-21 2011-04-12 Ferrosan Medical Devices A/S Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
ES2781475T3 (es) * 2002-09-18 2020-09-02 Janssen Pharmaceuticals Inc Métodos para aumentar la producción de células madre hematopoyéticas y plaquetas
US7955288B2 (en) 2002-12-11 2011-06-07 Ferrosan Medical Devices A/S Gelatine-based materials as swabs
CN1820024B (zh) * 2003-05-12 2011-06-22 阿费麦克斯公司 新的聚(乙二醇)修饰的化合物及其用途
US7919118B2 (en) * 2003-05-12 2011-04-05 Affymax, Inc. Spacer moiety for poly (ethylene glycol) modified peptide based compounds
JP2005187435A (ja) * 2003-12-26 2005-07-14 Otsuka Chemical Co Ltd 血小板産生促進組成物
CA2554994C (en) 2004-01-30 2015-05-19 Ferrosan A/S Haemostatic sprays and compositions
KR20070046093A (ko) 2004-07-09 2007-05-02 훼로산 아크티에 셀스카브 히알루론산을 포함하는 지혈 조성물
WO2007088849A1 (ja) * 2006-01-31 2007-08-09 Mitsubishi Kagaku Iatron, Inc. 播種性血管内凝固症候群の病態把握方法
CA2716872C (en) 2008-02-29 2015-02-10 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
WO2012157586A1 (ja) * 2011-05-13 2012-11-22 国立大学法人東京大学 多核化巨核球細胞、及び血小板の製造方法
CN104159527B (zh) 2012-03-06 2017-04-12 弗罗桑医疗设备公司 包含止血糊剂的压力容器
RU2636240C2 (ru) 2012-06-12 2017-11-21 Ферросан Медикал Дивайсиз А/С Сухая гемостатическая композиция
JP6390873B2 (ja) 2013-06-21 2018-09-19 フェッローサン メディカル ディバイス エー／エス 減圧膨張させた乾燥組成物およびそれを保持するためのシリンジ
BR112016013322B1 (pt) 2013-12-11 2020-07-21 Ferrosan Medical Devices A/S métodos para preparação de uma composição seca e para reconstituir uma composição seca, composição seca, uso de uma composição seca, e, kit
BR112017007466B1 (pt) 2014-10-13 2021-03-02 Ferrosan Medical Devices A/S método para preparar uma composição seca, método para reconstituir a composição seca, pasta, composição seca, recipiente, kit homeostático, e, uso de uma composição seca
RU2705905C2 (ru) 2014-12-24 2019-11-12 Ферросан Медикал Дивайсиз А/С Шприц для удерживания и смешивания первого и второго веществ
CA2986981A1 (en) 2015-07-03 2017-01-12 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
EP4321182A3 (en) 2018-05-09 2024-05-29 Ferrosan Medical Devices A/S Method for preparing a haemostatic composition
WO2026005476A1 (ko) * 2024-06-26 2026-01-02 주식회사 넥스세라 혈소판 감소증 치료를 위한 재조합 단백질 및 이의 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5498599A (en) * 1994-01-21 1996-03-12 Amgen Inc. Methods for stimulating platelet production
AU6046696A (en) * 1995-06-07 1996-12-30 Glaxo Group Limited Peptides and compounds that bind to a receptor
US6342220B1 (en) * 1997-08-25 2002-01-29 Genentech, Inc. Agonist antibodies
EP1064015A2 (en) * 1998-02-24 2001-01-03 Receptron, Inc. Receptor derived peptides as modulators of receptor activity

Also Published As

Publication number Publication date
SK15262002A3 (sk) 2003-05-02
YU79202A (sh) 2006-01-16
EE200200610A (et) 2004-08-16
BG107214A (bg) 2003-11-28
EP1278849A2 (en) 2003-01-29
GEP20063763B (en) 2006-03-10
AR030278A1 (es) 2003-08-20
EA006423B1 (ru) 2005-12-29
BR0110383A (pt) 2003-01-21
US20030181659A1 (en) 2003-09-25
EA200201138A1 (ru) 2003-06-26
WO2001080873A3 (en) 2002-01-31
AU2001267366B2 (en) 2005-06-30
AU2001267366B9 (en) 2005-07-14
NO20025114L (no) 2002-12-18
IL152204A0 (en) 2003-05-29
CA2407167A1 (en) 2001-11-01
NO20025114D0 (no) 2002-10-24
PL358304A1 (en) 2004-08-09
HUP0300559A2 (hu) 2003-06-28
AU6736601A (en) 2001-11-07
WO2001080873A2 (en) 2001-11-01
HUP0300559A3 (en) 2005-09-28
CN1426467A (zh) 2003-06-25
MXPA02010458A (es) 2003-06-06
KR20030009450A (ko) 2003-01-29
JP2003530867A (ja) 2003-10-21
EP1149906A1 (en) 2001-10-31
CZ20023517A3 (cs) 2003-10-15
ZA200208662B (en) 2003-10-27

Similar Documents

Publication Publication Date Title
IS6582A (is) Mótunarpeptíð fyrir blóðkökkmyndunarviðtaka
ITTO20010008A0 (it) Formulazione farmaceutica
ATE431145T1 (de) Missbrauchssichere orale opioid-agonist zubereitungen
NO20071303L (no) Farmasoytiske preparater
DE60038698D1 (de) Hydrogel-gesteuerte dosierungsform
DK1189853T3 (da) Betonformulering
DE50015294D1 (de) Mikrotom
FIU20000164U0 (fi) Uusi farmaseuttinen formulaatio
ID29336A (id) Zat perekat
DE50104433D1 (de) Desodorierende Zubereitungen
IS7571A (is) Ný lífeðlisfræðilega virk efni
ATE263487T1 (de) Flüssige formulierungen
NO20020151D0 (no) Veksthormonformuleringer
DE60122873D1 (de) Therapeutische porenbildende peptide
EP1171152A4 (en) VMIP-II PEPTIDE ANTAGONISTS OF CXCR4
DE50009946D1 (de) Schädlingsbekämpfungsmittel/depsipeptide
NO990937L (no) Kunstig rev
DE60104126D1 (de) Fungizide formulierung
AR025867A1 (es) Formulacion portasdora farmaceutica
EP1159288A4 (en) ALPHA-CONOTOXIN PEPTIDES
DE60012953D1 (de) 3-amino-2-phenylpiperidinderivate als substanz p antagonisten
NO20004816D0 (no) Ny farmasøytisk formulering
IT250089Y1 (it) Guanto per uso cosmetico
NO20041291D0 (no) Medisinske preparater som inneholder angiotensin II-reseptorantagonist
EP1151100A4 (en) TAU-CONOTOXIN PEPTIDE